OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-12-31-accounts

Page
Report ofthe Trustees 1 to 10
Report ofthe Independent
Auditors		 11 to 14
Statemeat ofFinancial Activities 15
Balance Sheet 16
Cash Flow Statement 17
Notes to the Cash Flow Statement 18
Notes to the Financial Statements 19 to 30

31.12.22 31.12.21
Unrestricted Restricted Endowment Total Total
fund funds fund funds funds
INCOME AND Notes $ $ $ $ $
ENDOWMENTS
FROM
Donations and legacies 3 1,403,129 300,352 1,703,481 466,758
Other trading activities 4 14,991 14,991
Investment
income		 5 202825' 3,777 206,402 154,858
Total 300,352 3,777 1,924,874 621,616
EXPENDITURE ON
Raising funds 6 160,820 2255 163,075 390,095
Charitable
activities
Support the operational costs of
the RDTC in Moshi
IFDgeneral activities
Student sponsorship
ILDSactivities
Community
Skin Health Journal
Global Psoriasis Atlas
World Congress ofDermatology
WHO activities		 93,364
160,383
1302,542
99,226
81,669
90,912
9ir752		 151,180
122,032
112,200
73,684
15,978		 244,544
282,415
112,200
1,202,542
172,910
97,647
90,912
99,162		 109,992
211,480
125,568
156,442
61,354
62,092
114,342
180,147
Total 475,074 2,255 2,465,407 1,411,512
Net gains/(losses)
on
investments (T7105i792) (60,580) (1,869,772) 29,885
NET
INCOME/(EXPENDITURE)
Transfers between funds		 (2,176,525)
18 ~079Z)		 (174,722)
280,792		 (59,058) (2,410,305) (760,011)
Net movement
in funds		 (2,457,317) 106,070 (59,058) (2,410,305) (760,011)
RECONCILIATION OF
FUNDS
Total funds brought forward 14,379,592 277,412 1,133,561 15,790,565 16,550,576
TOTAL FUNDS CARRIED
FORWARD

31.12.22 31.12.21
Unrestricted Restricted Endowment Total Total
fund funds fund funds funds
Notes $ $ $ $ $
FIXEDASSETS
Tangible assets 14 64,334 64,334 6,823
Investments 15 11,670,341 669,699 12,340,040 12,386,009
11,734,675 669,699 12,404,374 12,392,832
CURRENT ASSETS
Debtors 16 14,225 14,225 33,135
Cash atbank and in hand 591,752 383,482 404,804 1,380,038 3,403,157
605,977 383,482 404,804 1,394,263 3,436,292
CREDITORS
Amounts
falling due within one
year 17 (418,377) (418,377) (38,559)
NET CURRENT ASSETS 187,600 383,482 404,804 975,886 3,397,733
TOTAL ASSETSLESS
CURRENT LIABILITIES 11,922,275 383,482 1,074,503 13,380,260 15,790,565
NET ASSETS 11,922,275 383,482 1,074,503 13,380,260 15,790,565
FUNDS 18
Unrestricted
funds		 11,922,275 14,379,592
Restricted funds 383,482 277,412
Endowment
funds		 1,074,503 1,133,561
TOTAL FUNDS 13,380,260 15,790,565

31.12.22 31.12.21
Notes $ $
Cash flows from operating
activities
Cash generated
&om operations		 (344335) (1,005,896)
Net cash used in operating activities (344,235) (1,005,896)
Cash flows from investing
activities
Purchase oftangible fixed assets
Purchase offixed asset investments
Saleoffixed asset investments		 (63,005)
(4,033,439)
2,209,636		 (2,562)
(12,414,303)
5,901,887
Interest received 206,402 154,858
Net cash used in investing
activities		 (1,680,406) (6,360,120)
Cash flows from financing
activities
Income attributable
toendowment		 3777 22,093
Expenditure
attributable
to endowment		 (2,255) (2,935)
Net cash provided by financing
activities		 1,522 19,158
Change in cash and cash equivalents in
the reporting period
Cash and cash equivalents
at the		 (2,023,119) (7,346,858)
beginning ofthe reporting
period		 3,403,157 10,750,015
Cash and cash equivaleats
at the end		 of
the reporting
period		 1,380,038 3,403,157


ACTIVITIES		 OPERATIN
31.12.22 31.12.21
Net expeaditure
for the reporting		 period (as per the Statement of $ $
Financial Activities)
Adjustments
for:		 (2,410,305) (760,011)
Depreciation
charges
Losses/(gain)
on investments
Interest received
Income attributable
to endowment
Expenditure
attributable
to endowment
Decrease/(increase)
in debtors
Increase/(decrease)
in creditors		 5,494
1,869,772
(206,402)
(3,777)
2,255
18,910
379,818		 2,023
(29,885)
(154,858)
(22,093)
2,935
(19,618)
(24,389)
Net cash used in operations (344435) (1,005,896)
ANALYSIS OFCHANGES IN NET FUNDS
At 1.1.22 Cash flow At31.12.22
$ $ $
Net cash
Cash atbank and in hand 3,403,157 (2,023,119) 1,380,038
3,403,157 (2,023,119) 1,380,038
Total 3,403,157 (2,023,119) 1,380,038

4. OTHER TRADING A CTIVITIES
31.12.22 31.12.21
World congress bidding fees $ 14,991 $
5. INVESTMENT INCOME
31.12.22 31.12.21
Porlfolio income
Bank interest		 $ 206,402 $ 154,829
29
206,402 154,858
RAISING FUNDS
Raising donations
and		 legacies
31.12.22 31.12.21
Supportcosts $ 110,153 $ 359,906
An analysis ofsupport costs is provided in note 8.
Investment
management		 costs
31.12.22 31.12.21
Portfolio management $ 52,922 $ 30,189
Aggregate
amounts		 163,075 390,095
7. CHARITABLE ACTIVITIES COSTS
Grant
funding of
activities Support
Direct (seenote costs (see
Costs 8) note 9) Totals
Support the operational
costs ofthe		 $ $ $ $
RDTC in Moshi
IFDgeneral activities
Student sponsorship
ILDSactivities
Community
Skin Health Journal
Global Psoriasis Atlas
World Congress ofDermatology
WHO activities		 151,180
69,399
112,200
379,195
73,684
25,799
2,678
9,623		 52,350
257,642		 93,364
160,666
565,705
99326
71,848
88,234
89,539		 244,544
282,415
112,200
1,202,542
172,910
97,647
90,912
99,162
823,758 309,992 1,168,582 2,302,332

Kings College - London $34,099
Charite University -Berlin $64,038
Standing Voice $55,505
Massachusetts
General Hospital
Mexico
Dermlink		 $75,000
$10,000
$42,350

SUPPORT COSTS
Human Governance
Management Finance resources cost's Totals
Raising donations
and		 $ $ $ $
legacies
Support the operational		 85,906 20,652 2,398 1,197 110,153
costs ofthe RDTC in Moshi
IFDgeneral activities
ILDSactivities
Community
Skin Health		 69,731
130364
313,799		 20,038
20,436
20,252		 2,398
2,398
2,398		 1,197
7,568
229,256		 93,364
160,666
565,705
Journal
Global Psoriasis Atlas
World Congress of		 75,660
47,310		 19,969
20,164		 2,399
2,399		 1,198
1,975		 99,226
71,848
Dermatology
WHO activities		 57,895
64,032		 20,141
20,000		 2,399
2415		 7,799
3,292		 88,234
89,539
844,597 161,652 19,004 253,482 1478,735
Support costs, included in the above, are as follows
Support
the
Raising
donations		 operational
costsof		 IFD Community
Skin
and the RDTC general ILDS Health
legacies in Moshi activities activrttes Journal
Administration
salaries
Social security
Pensions
Office rent and related costs
Recruitment
fees
Meetings and travel
Website
Postage and stationery
Branding
Sundries
Legal, professional
and		 $ 61,500
4,828
1,540
2,852
8,200
6,986		 $ 54,411
4,828
1,350
2,852
6490		 $ 85,300
4,829
1,540
2,852
33,238
2,505		 $ 100,200
6,439
1,591
2,859
49,305
3341
389
68,963
1,427		 $ 35,500
4,829
2,853
15,406
7,417
9,655
accountancy 34,690
Carried forward 85,906 69,731 130,264 269,104 75,660

SUPPORT C OST S - continued
Support
the
Raising operational Community
donations costsof IFD Skin
and the RDTC general ILDS Health
legacies in Moshi activities activities Journal
$ $ $ $ $
Brought forward 85,906 69,731 130,264 269,104 75,660
Tfanlnlg 15,866
President support costs 28,829
Bank charges 385 385 576 439 369
Foreign exchange variance 19,113 19,112 19,112 19,112 19,112
Depreciation oftangible
fixed assets 1,154 541 748 701 488
HR support 2,398 2,398 2,398 2,398 2,399
Auditprs'
remunerhfion		 1,197 1,197 1,197 1307 1,198
Legal Tees 6,371 55,602
Trainhtg algl resources 11,509
Board meeLhrg costs 160,938
110,153 93,364 160,666 565,705 99,226
31.12.22 31.12.21
World
Global Congress
Psoriasis of WHO Total Total
Atlas Dermatology activities activities activities
$ $ $ $ $
Administration salaries 30,500 48,000 47,088 462,499 461,000
Social security 4,829 4,829 4,829 40,240 40,320
Pensions 1,912 1,912 1,542 11,387 19,489
OAice rent and related costs 2,853 2,853 2,853 22,827 14,189
Recruitment fees 2,000 25,606 41,753
Meetings and travel 7,216 69,797 1,658
Website 43,896 12,433
Postage and stationery 301 690 1,208
Branding 81,123 18,215
Sundries 1,427 301
Legal, professional and
accountancy 5,720 40,410 60,768
Tfaliinlg 15,866 4,273
President support costs 28,829 5,242
Bank charges 369 369 369 3,261 3,579
Foreign exchange variance 19,112 19,112 19,112 152,897 191,827
Depreciation oftangible
fixed assets 683 660 519 5,494 2,023
HR support 2,399 2,399 2315 19,004
Auditors'
remuneration		 1,198 1,198 1,198 9,590 9,101
Legal fees 777 6,601 2,094 71,445
Training and resources 11,509
Board meeting costs 160,938
71,848 88,234 89,539 1,278,735 887,379

STAFFCOSTS
Staff costs for the year were $514,126 (2021 - $519,679), in respect of nine members of administration staff
based in the UK and these are analysed as follows:
2022 2021
$ $
Agency and subcontract staff 51,430 19,300
Wages and salaries 411,069 440,573
Social security costs 40,240 40,318
Employer contributions to defined contribution pension schemes 11,387 19,488
514,126 519,679

COMPARATIVKS FORTHE STATEMENT OFFINANCIAL COMPARATIVKS FORTHE STATEMENT OFFINANCIAL ACTIVITIES
Unrestricted Restricted Endowment Total
fund funds fund funds
$ $ $ $
INCOME AND ENDOWMENTS FROM
Donations
and legacies		 156,226 310,532 466,758
Investment
income		 132,765 22,093 154,858
Total 288,991 310,532 22,093 621,616
EXPENDITURE ON
Raising funds 387,160 2,935 390,095
Charitable
activities
Support the operational costsofthe RDTC in
Moshi 24,234 85,758 109,992
IFDgeneral activities 125,598 85,882 211,480
Student sponsorship 125,568 125,568
ILDSactivities 156,442 156,442

13. COMPARATIVES FORTHE STATEMENT OFFINANCIAL ACTIVITIES -continued ACTIVITIES -continued
Unrestricted Restricted Endowment Total
fund funds fund funds
$ $ $ $
Community
Skin Health Journal		 8,575 52,779 61,354
Global Psoriasis Atlas 59,821 2,271 62,092
World Congress ofDermatology 114,342 114,342
WHO activities 180,147 180,147
Total 1,056,319 352,258 2,935 1,411,512
Net gains/(losses)
on investments		 64,722 (34,837) 29,885
NKT INCOME/(EXPENDITURE) (702,606) (41,726) (15,679) (760,011)
Transfers between funds (137,195) 137,195
Net movement
in funds		 (839,801) 95,469 (15,679) (760,011)
RECONCILIATION OFFUNDS
Total funds brought forward 15,219,393 181,943 1,149240 16,550,576
TOTAL FUNDS CARRIED FORWARD 14,379,592 277,412 1,133,561 15,790,565
14. TANGIBLE FIXEDASSETS
Plant and Office
machinery equipment Totals
$ $ $
COST
At 1January 2022 18,569 18,569
Additions 60,622 2,383 63,005
At 31December 2022 60,622 20,952 81,574
DEPRECIATION
At 1January 2022 11,746 11,746
Charge foryear 3,789 1,705 5,494
At 31December 2022 3,789 13,451 17,240
NET BOOKVALUE
At 31December 2022 56,833 7,501 64,334
At 31December 2021 6,823 6,823

FIXEDASSETINVESTMENTS
Cash and
Listed settlements
investments perldlrlg Totals
$ $ $
MARKET VALUE
At I January 2022 12,386,009 12,386,009
Additions 2,363,115 1,670,324 4,033,439
Disposals (1,611,241) (598,395) (2309,636)
Revaluations (1,869,772) (1,869,772)
At 31December 2022 11,268,111 1,071,929 12,340,040
NKT BOOK VALUE
At 31December 2022 11,268,111 1,071,929 12,340,040
At 31December 2021 12,386,009 12,386,009

Cash and
Listed settlements
investments pending Totals
$ $ $
Valuation in 2022 11368,111 1,071,929 12,340,040
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.22 31.12.21
$ $
Trade debtors 2,715 (1,373)
Prepayments and accrued income 11,510 34,508
14,225 33,135

CREDITOR S: AMOUNTS FA LLING D UE WITHIN ONE YEAR
31.12.22 31.12.21
$ $
Trade creditors 268 5,306
Other creditors 5,907 11,044
Accruals and deferred income 412,202 22,209
418,377 38,559
MOVEMENT IN FUNDS
Net Transfers
movement between At
At 1.1.22 in funds funds 31.12.22
8 $ $ $
Unrestricted funds
General fund 14,379,592 (2,176,525) (280,792) 11,922,275
Restricted funds
IFDGeneral 44,963 44,963
IFDRDTC (208,380) 208,380
IFDCommunity Skin Health Journal (72,412) 72,412
ILDSGlobal Psoriasis Atlas 277,412 61,107 338,519
277,412 (174,722) 280,792 383,482
Endowment funds
IFD(Moshi RDTC) Endowment Fund 1,133,561 (59,058) 1,074,503
TOTAL FUNDS 15,790,565 (2,410,305) 13,380,260
Net movement in funds, included in the above are as follows:
Incoming Resources Gains and Movement
resources expended losses in funds
$ $ $ $
Unrestricted funds
General fund 1,620,745 (1,988,078) (1,809,192) (2,176,525)
Restricted funds
IFDGeneral
IFDRDTC
IFDCommunity
Skin Health Journal
ILDSGlobal Psoriasis Atlas		 166,995
55,000
1,272
77,085		 (122,032)
(263,380)
(73,684)
(15,978)		 44,963
(208,380)
(72,412)
61,107
Endowment funds 300,352 (475,074) (174,722)
IFD(Moshi RDTC) Endowment Fund 3777 (2,255) (60,580) (59,058)
TOTAL FUNDS 1,924,874 (2,465,407) (1,869,772) (2,410,305)

Net Transfers
movement between At
At 1.1.21 in funds funds 31.12.21
$ $ $ $
Unrestricted funds
General fund 15419,393 (702,606) (137,195) 14,379,592
Restricted funds
IFDGeneral
IFDRDTC		 (36,643)
(24,117)		 36,643
24,117
IFDCommunity Skin Health Journal (51,206) 51,206
IFDPersons with Albinism (15,229) 15,229
IFDIACS (10,000) 10,000
ILDSGlobal Psoriasis Atlas 181,943 95,469 277,412
181,943 (41,726) 137,195 277,412
Endowment funds
IFD(Moshi RDTC) Endowment Fund 1,149,240 (15,679) 1,133,561
TOTAL FUNDS 16,550,576 (760,011) 15,790,565
Incoming Resources Gains and Movement
resources expended losses in funds
$ 8 $ $
Unrestricted funds
General fund 288,991 (1,056,319) 64,722 (702,606)
Restricted funds
IFDGeneral
IFDRDTC		 24,010
187,209		 (60,653)
(211,326)		 (36,643)
(24,117)
IFDCommunity Skin Health Journal 1,573 (52,779) (51,206)
IFDPersons with Albinism (15,229) (15,229)
IFDIACS (10,000) (10,000)
ILDSGlobal Psoriasis Atlas 97,740 (2371) 95,469
310,532 (352,258) (41,726)
Endowment funds
IFD(Moshi RDTC) Endowment Fund 22,093 (2,935) (34,837) (15,679)
TOTAL FUNDS 621,616 (1,411,512) 29,885 (760,011)